BRIEF published on 06/04/2025 at 10:36, 10 months 17 days ago Safran : Transactions sur actions du 27 au 30 mai 2025 Actions Propres Safran Transactions Natixis Mai 2025
BRIEF published on 06/04/2025 at 10:36, 10 months 17 days ago Safran Conducts Significant Share Buyback from May 27th to 30th, 2025 Safran Share Buyback Natixis Stock Market May 2025
BRIEF published on 06/04/2025 at 10:35, 10 months 17 days ago SUSS MicroTec SE AGM Approves 50% Dividend Increase and Re-Elects Jan Smits Shareholder Approval Dividend Increase Company Growth 2025 Outlook Jan Smits Re-Election
BRIEF published on 06/04/2025 at 10:35, 10 months 17 days ago L'assemblée générale annuelle de SUSS MicroTec SE approuve une augmentation de 50 % du dividende et réélit Jan Smits Croissance De L'entreprise Approbation Des Actionnaires Perspectives 2025 Augmentation Des Dividendes Réélection De Jan Smits
BRIEF published on 06/04/2025 at 10:05, 10 months 17 days ago Mallia Innovations Charts Future with €5.5 Million Financing Hair Loss Treatment Cosmetic Applications SCD83 Protein Mallia Innovations €5.5 Million Financing
BRIEF published on 06/04/2025 at 10:05, 10 months 17 days ago Mallia Innovations se projette dans l'avenir avec un financement de 5,5 millions d'euros Traitement De La Perte De Cheveux Protéine SCD83 Mallia Innovations Applications Cosmétiques Un Financement De 5,5 Millions D'euros
BRIEF published on 06/04/2025 at 10:05, 10 months 17 days ago Leon-nanodrugs Appoints Dr. Wolfgang Hofmann as CEO Amid Market Expansion Market Expansion Leon-nanodrugs GmbH Pharmaceutical Advancements Wolfgang Hofmann FR-JET® Technology
BRIEF published on 06/04/2025 at 10:05, 10 months 17 days ago Leon-NanoDrugs nomme le Dr Wolfgang Hofmann au poste de PDG dans le cadre de son expansion commerciale Leon-nanodrugs GmbH Expansion Du Marché Wolfgang Hofmann Technologie FR-JET® Progrès Pharmaceutiques
BRIEF published on 06/04/2025 at 10:05, 10 months 17 days ago Molecular Health and Axxam Announce Strategic Partnership in Drug Development Drug Development Biopharmaceutical AI Insights Dataome DiscoveryMAXX
BRIEF published on 06/04/2025 at 10:05, 10 months 17 days ago Molecular Health et Axxam annoncent un partenariat stratégique pour le développement de médicaments Biopharmaceutique Développement De Médicaments Informations Sur L'IA Dataome DiscoveryMAXX
Published on 04/22/2026 at 01:55, 3 hours 15 minutes ago Immutable Holdings Announces Director Resignation
Published on 04/22/2026 at 01:30, 3 hours 40 minutes ago Challenger West Assays Return Grades up to 60g/t Au
Published on 04/22/2026 at 00:00, 5 hours 10 minutes ago Zimtu Capital Corp. and Global Energy Metals Corporation Agree to Terminate Option Agreement for the Monument Peak Copper-Silver Project, Idaho
Published on 04/22/2026 at 00:00, 5 hours 10 minutes ago Grande Portage Resources Announces SEDAR+ Filing of Preliminary Economic Assessment (PEA) Study for the New Amalga Gold Project in SE Alaska
Published on 04/21/2026 at 22:15, 6 hours 55 minutes ago Amrize Shareholders Approve All Proposals at 2026 Annual General Meeting
Published on 04/21/2026 at 20:50, 8 hours 19 minutes ago CATL Unveils Six Major Innovations: Multi-Chemistry Systems to Redefine New Energy Mobility Experience
Published on 04/21/2026 at 19:15, 9 hours 55 minutes ago Shelly Group SE publishes 2025 Investors Report as an established transparency format
Published on 04/21/2026 at 19:08, 10 hours 1 minute ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 04/21/2026 at 19:02, 10 hours 7 minutes ago Brockhaus Technologies AG: Actions for annulment and nullity against the approval resolution of the Extraordinary General Meeting of February 26, 2026
Published on 04/21/2026 at 19:15, 9 hours 55 minutes ago AXA - Description of the Company’s share repurchase program
Published on 04/21/2026 at 19:15, 9 hours 55 minutes ago AXA - Descriptif du programme de rachat d’actions
Published on 04/21/2026 at 18:00, 11 hours 10 minutes ago Outstanding shares and voting rights statement at 31 March 2026
Published on 04/21/2026 at 18:00, 11 hours 10 minutes ago Publication du nombre d’actions composant le capital et du nombre total de droits de vote au 31 mars 2026
